Nikhil Lalwani sold $401K of ANI Pharmaceuticals (ANIP)

Executed Aug 25, disclosed Aug 26, 1 day later.

Value, as filed

$401K

5,400 sh × $74.30

Executed

Aug 25

the trade date, as filed

Disclosed

Aug 26

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Nikhil Lalwani PRESIDENT & CEO profile →

Nikhil Lalwani (PRESIDENT & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $4.3M of ANIP (55,000 sh × $77.57, as filed), executed May 11.

The name

ANIP

ANI Pharmaceuticals, Inc. ANIP · Healthcare · 47 filings in 24 months ticker →

Healthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Nikhil Lalwani in ANIP

ANIPSALE ANI Pharmaceuticals, Inc. $383K
5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $4.3M
55,000 sh × $77.57
Exec May 11
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $4.9M
56,960 sh × $85.93
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $1.9M
33,481 sh across 2 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET